These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 34151525)

  • 1. Pathogenesis of sporadic Alzheimer's disease by deficiency of NMDA receptor subunit GluN3A.
    Zhong W; Wu A; Berglund K; Gu X; Jiang MQ; Talati J; Zhao J; Wei L; Yu SP
    Alzheimers Dement; 2022 Feb; 18(2):222-239. PubMed ID: 34151525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strain hypothesis and additional evidence of the GluN3A deficiency-mediated pathogenesis of Alzheimer's disease.
    Yu SP; Jiang M; Berglund K; Wei L
    Alzheimers Dement; 2023 Sep; 19(9):4267-4269. PubMed ID: 37485581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer's disease.
    Yu SP; Jiang MQ; Shim SS; Pourkhodadad S; Wei L
    Mol Neurodegener; 2023 Jul; 18(1):43. PubMed ID: 37400870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the NMDA receptor subunit GluN3A (NR3A) in the olfactory system and its regulatory role on olfaction in the adult mouse.
    Lee JH; Wei L; Deveau TC; Gu X; Yu SP
    Brain Struct Funct; 2016 Jul; 221(6):3259-73. PubMed ID: 26334321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence for cognitive decline or neurodegeneration in strain-matched Grin3a knockout mice.
    Verhaeghe R; Elía-Zudaire O; Escamilla S; Sáez-Valero J; Pérez-Otaño I
    Alzheimers Dement; 2023 Sep; 19(9):4264-4266. PubMed ID: 37483152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired social behaviors and minimized oxytocin signaling of the adult mice deficient in the N-methyl-d-aspartate receptor GluN3A subunit.
    Lee JH; Zhang JY; Wei ZZ; Yu SP
    Exp Neurol; 2018 Jul; 305():1-12. PubMed ID: 29554474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A neuroprotective role of the NMDA receptor subunit GluN3A (NR3A) in ischemic stroke of the adult mouse.
    Lee JH; Wei ZZ; Chen D; Gu X; Wei L; Yu SP
    Am J Physiol Cell Physiol; 2015 Apr; 308(7):C570-7. PubMed ID: 25652449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-methyl-D-aspartate receptor-mediated calcium influx connects amyloid-β oligomers to ectopic neuronal cell cycle reentry in Alzheimer's disease.
    Kodis EJ; Choi S; Swanson E; Ferreira G; Bloom GS
    Alzheimers Dement; 2018 Oct; 14(10):1302-1312. PubMed ID: 30293574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Effects of Pharmacologic and Genetic Modulation of NMDA Receptor Activity on HIV/gp120-Induced Neuronal Damage in an In Vivo Mouse Model.
    Nakanishi N; Kang YJ; Tu S; McKercher SR; Masliah E; Lipton SA
    J Mol Neurosci; 2016 Jan; 58(1):59-65. PubMed ID: 26374431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GluN3A promotes NMDA spiking by enhancing synaptic transmission in Huntington's disease models.
    Mahfooz K; Marco S; Martínez-Turrillas R; Raja MK; Pérez-Otaño I; Wesseling JF
    Neurobiol Dis; 2016 Sep; 93():47-56. PubMed ID: 27072890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine phosphorylation regulates the endocytosis and surface expression of GluN3A-containing NMDA receptors.
    Chowdhury D; Marco S; Brooks IM; Zandueta A; Rao Y; Haucke V; Wesseling JF; Tavalin SJ; Pérez-Otaño I
    J Neurosci; 2013 Feb; 33(9):4151-64. PubMed ID: 23447623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
    Lipton SA
    J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunction of GluN3A subunit is involved in depression-like behaviors through synaptic deficits.
    Zhang M; Kong X; Chen J; Liu W; Liu C; Dou X; Jiang L; Luo Y; Song M; Miao P; Tang Y; Xiu Y
    J Affect Disord; 2023 Jul; 332():72-82. PubMed ID: 36997126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
    Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
    Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMDA Receptor Antagonists: Repositioning of Memantine as a Multitargeting Agent for Alzheimer's Therapy.
    Kabir MT; Sufian MA; Uddin MS; Begum MM; Akhter S; Islam A; Mathew B; Islam MS; Amran MS; Md Ashraf G
    Curr Pharm Des; 2019; 25(33):3506-3518. PubMed ID: 31604413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory roles of the NMDA receptor GluN3A subunit in locomotion, pain perception and cognitive functions in adult mice.
    Mohamad O; Song M; Wei L; Yu SP
    J Physiol; 2013 Jan; 591(1):149-68. PubMed ID: 23006484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathologic changes in Alzheimer's disease: potential targets for treatment.
    Wenk GL
    J Clin Psychiatry; 2006; 67 Suppl 3():3-7; quiz 23. PubMed ID: 16649845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures.
    Ferreira IL; Bajouco LM; Mota SI; Auberson YP; Oliveira CR; Rego AC
    Cell Calcium; 2012 Feb; 51(2):95-106. PubMed ID: 22177709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine.
    Nyakas C; Granic I; Halmy LG; Banerjee P; Luiten PG
    Behav Brain Res; 2011 Aug; 221(2):594-603. PubMed ID: 20553766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NMDA receptor subunit GluN3A protects against 3-nitroproprionic-induced striatal lesions via inhibition of calpain activation.
    Martínez-Turrillas R; Puerta E; Chowdhury D; Marco S; Watanabe M; Aguirre N; Pérez-Otaño I
    Neurobiol Dis; 2012 Dec; 48(3):290-8. PubMed ID: 22801082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.